<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-VWQB2IDB</identifier><date>2005</date><creator>Kristl, Jernej</creator><relation>documents/doc/V/URN_NBN_SI_doc-VWQB2IDB_001.pdf</relation><relation>documents/doc/V/URN_NBN_SI_doc-VWQB2IDB_001.txt</relation><format format_type="issue">2</format><format format_type="volume">44</format><format format_type="type">article</format><format format_type="extent">str. 171-182</format><identifier identifier_type="ISSN">0025-8121</identifier><identifier identifier_type="COBISSID">1776241</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-VWQB2IDB</identifier><language>slv</language><publisher>Medicinski razgledi</publisher><source>Medicinski razgledi</source><rights>InC</rights><subject language_type_id="slv">citokini</subject><subject language_type_id="slv">farmakologija</subject><subject language_type_id="slv">kožne bolezni</subject><subject language_type_id="slv">luskavica</subject><subject language_type_id="slv">monoklonalna protitelesa</subject><subject language_type_id="slv">rekombiantni proteini</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Recombinant human protein - new palette of drugs for the treatment of psoriasis</title><title>Rekombinantni človeški proteini - nov nabor učinkovin za zdravljenje luskavice</title></Record>